Funder
National Natural Science Foundation of China
Reference30 articles.
1. World Health Organization. Respiratory syncytial virus (RSV) disease. 2023 https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/respiratory-syncytial-virus-disease. Accessed 1/12/2023.
2. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study;Shi;Lancet,2017
3. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study;Wildenbeest;Lancet Respir Med,2023
4. World Health Organization. Guidelines on the quality, safety and efficacy of respiratory syncytial virus vaccines. 2020 https://www.who.int/publications/m/item/respiratory-syncytial-virus-vaccines-annex-2-trs-no-1024. Accessed 1/12/2023.
5. Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: A systematic literature review and meta-analysis;Savic;Influenza Other Respir Viruses,2023